IVIG May Improve Neurological Symptoms in MIS-C

Recent case series findings, as well as previous studies, show that children with multisystem inflammatory syndrome (MIS-C) who present with signs of active neurological symptoms may show improvement with intravenous immune globulin (IVIG) and corticosteroids.

Study Finds Adult Vaccines Potentially Protect Against Alzheimer’s

A new study conducted at the University of Texas Health Science Center at Houston found that people who received shingles and pneumonia vaccines — along with tetanus and diphtheria — had as much as a 30 percent reduced risk of developing Alzheimer’s the most common type of dementia.

FDA Approves Pfizer’s ABRYSVO Vaccine for the Prevention of RSV

Pfizer’s ABRYSVO, a respiratory syncytial virus (RSV) vaccine, has been approved by the U.S. Food and Drug Administration for the prevention of lower respiratory tract disease (LRTD) and severe LRTD caused by RSV in infants from birth up to 6 months of age by active immunization of pregnant women at 32 through 36 weeks gestational age.

Mpox: Lessons Learned

The U.S. Monkeypox (mpox) public health emergency formally ended in early 2023. Yet, while mpox isn’t completely gone, the average number of daily cases has dwindled into the single digits. Still, many questions for public health officials remain.

Study Finds Experimental Alzheimer’s Drug Slows Cognitive Decline

A large clinical trial of Eli Lilly’s experimental Alzheimer’s medication, donanemab found the drug slowed declines in patients’ ability to think clearly and perform daily tasks by more than a third.

Myths & Facts: Autism (2023)

Dispelling the myths surrounding this condition can help parents and caregivers support individuals with ASD, as well as clear up stereotypes and misunderstandings often associated with it.

A Primer on Mpox

Most human cases of this zoonotic virus are mild, but knowing the signs, symptoms and preventive measures for transmitting this disease remains important for public health.

Update on Toxoplasmosis

Because there is no cure or vaccine for this widespread parasitic infection, knowing how toxoplasmosis is spread and best practices for preventing transmission remains important.

Study Finds IVIG Effective for Treating Dermatomyositis

A study evaluating intravenous immune globulin for the treatment of dermatomyositis has found it significantly improved patient outcomes.

First Malaria Vaccine Prequalified by WHO

The World Health Organization has prequalified the first malaria vaccine, RTS,S/AS01 (also known as Mosquirix), manufactured by GSK, bringing it closer to reaching millions more children at risk of malaria.